Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...
Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...
We read with great interest the article by Henniger et al 1 about reducing scope 3 carbon emissions in endoscopy and would like to discuss several points. First, we commend the study’s transparency, ...
Correspondence to: MrC D Johnson University Surgical Unit, Mail Point 816, Southampton General Hospital, Southampton BH24 4EW, UK; c.d.johnsonsoton.ac.uk If you wish to reuse any or all of this ...
2 NIHR Biomedical Research Centre at Guy's and Saint Thomas' NHS Foundation Trust and King's College, London, UK The prevalence of IBD is rising in the Western world. Despite an increasing repertoire ...
Correspondence to Professor Maria Gloria Dominguez-Bello, Department of Biochemistry and Microbiology, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901, USA; ...
Dr Z M Younossi, The Cleveland Clinic Foundation, Department of Gastroenterology, Desk S-40, 9500 Euclid Avenue, Cleveland, OH 44195, USA. BACKGROUND AND AIMS To develop and assess a disease specific ...
1 Christian Doppler Research Laboratory for Gut Inflammation and Department of Medicine, Division of Gastroenterology and Hepatology, Medical University Innsbruck, Austria 2 Department of Medicine “T” ...
1 University of Sheffield, School of Medicine and Biomedical Sciences, Academic Unit of Molecular and Clinical Pharmacology, The Royal Hallamshire Hospital, Sheffield, UK 2 Department of ...
Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China Correspondence to Dr Pinghong Zhou, Zhongshan Hospital Fudan University, Shanghai, Shanghai, ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
a Department of Hepatogastroenterology, Hôpital de l’Archet II, 151 Route de Saint Antoine de Ginestrière, 06202 Nice, France, b Regional Pharmacovigilance Center, Pasteur Hospital, Nice Dr P Hastier.